PTK2 and malignant colon neoplasm: Treatment with lunasin (an Arg-Gly-Asp, (RGD) cancer suppressor polypeptide) inhibits the activation of the FAK/ERK/NF-κB pathway in integrinα5β1-overexpressing cells, inhibiting the invasion and metastasis of colon cancer.